U.S. Physical Therapy (NYSE:USPH) Shares Gap Down on Disappointing Earnings

Shares of U.S. Physical Therapy, Inc. (NYSE:USPHGet Rating) gapped down prior to trading on Thursday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $126.87, but opened at $102.99. U.S. Physical Therapy shares last traded at $99.78, with a volume of 860 shares.

The company reported $0.90 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.93 by ($0.03). U.S. Physical Therapy had a net margin of 7.69% and a return on equity of 14.77%. The business had revenue of $140.70 million for the quarter, compared to analyst estimates of $143.01 million. During the same period in the prior year, the business earned $0.96 EPS. The company’s revenue for the quarter was up 10.9% compared to the same quarter last year.

U.S. Physical Therapy Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 16th. Stockholders of record on Thursday, August 18th will be issued a dividend of $0.41 per share. This represents a $1.64 dividend on an annualized basis and a dividend yield of 1.78%. The ex-dividend date is Wednesday, August 17th. U.S. Physical Therapy’s dividend payout ratio is currently 56.94%.

Wall Street Analysts Forecast Growth

Separately, TheStreet raised U.S. Physical Therapy from a “c+” rating to a “b-” rating in a report on Thursday, July 28th. One investment analyst has rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $121.50.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Citigroup Inc. raised its stake in U.S. Physical Therapy by 35.6% in the fourth quarter. Citigroup Inc. now owns 11,343 shares of the company’s stock valued at $1,084,000 after purchasing an additional 2,978 shares in the last quarter. Aptus Capital Advisors LLC raised its stake in U.S. Physical Therapy by 23.5% in the fourth quarter. Aptus Capital Advisors LLC now owns 27,179 shares of the company’s stock valued at $2,597,000 after purchasing an additional 5,166 shares in the last quarter. Qube Research & Technologies Ltd acquired a new position in U.S. Physical Therapy in the fourth quarter valued at about $676,000. Baker Tilly Wealth Management LLC raised its stake in U.S. Physical Therapy by 5.7% in the first quarter. Baker Tilly Wealth Management LLC now owns 2,261 shares of the company’s stock valued at $225,000 after purchasing an additional 122 shares in the last quarter. Finally, SG Americas Securities LLC raised its stake in U.S. Physical Therapy by 123.7% in the fourth quarter. SG Americas Securities LLC now owns 19,628 shares of the company’s stock valued at $1,875,000 after purchasing an additional 10,855 shares in the last quarter. Institutional investors and hedge funds own 99.13% of the company’s stock.

U.S. Physical Therapy Stock Performance

The firm has a market cap of $1.19 billion, a price-to-earnings ratio of 31.92 and a beta of 1.22. The stock has a 50 day moving average of $114.70 and a 200 day moving average of $104.76. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.40.

About U.S. Physical Therapy

(Get Rating)

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Recommended Stories

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.